Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-96-002340
Filing Date
1996-05-14
Accepted
1996-05-14 00:00:00
Documents
9
Period of Report
1996-03-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 10-Q 48003
2 COLLABORATIVE RESEARCH AGREEMENT - 4-1-96 EX-10.1 61210
3 LICENSE AGREEMENT - 4-1-96 EX-10.2 20742
4 STOCKHOLDERS' AGREEMENT - 4-23-96 EX-10.3 72384
5 COLLABORATIVE RESEARCH AGREEMENT - 4-23-96 EX-10.4 77076
6 REGISTRATION RIGHTS AGREEMENT EX-10.5 23367
7 FORM OF WARRANTS EX-10.6 28771
8 EMPLOYMENT AGREEMENT EX-10.7 25161
9 FINANCIAL DATA SCHEDULE EX-27 2056
  Complete submission text file 0000950123-96-002340.txt   361067
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
ONCOGENE SCIENCE INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 96564434
SIC: 2835 In Vitro & In Vivo Diagnostic Substances